Petition For Post-Grant Review Of Fusion Protein Patent Filed With Board
ALEXANDRIA, Va. — A recently issued patent claiming formulations that comprise a vascular endothelial growth factor (VEGF) antagonist fusion protein suffers from inadequate written description or, alternatively, would have been obvious...To view the full article, register now.
Already a subscriber? Click here to view full article